We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

UCB Announces Start of C-EARLY™ Study for Cimzia® in RA

News   Aug 23, 2012

 
UCB Announces Start of C-EARLY™ Study for Cimzia® in RA
 
 
Advertisement
 

RELATED ARTICLES

Trial of Saliva Test for COVID-19 Launched

News

Scientists from the Innovative Genomics Institute (IGI), the same UC Berkeley group that rapidly popped up a state-of-the-art COVID-19 testing laboratory in March, are now trialing a quicker way to obtain patient samples: through saliva.

READ MORE

Rewriting the Rules of Vaccine Design With DNA Origami

News

By folding DNA into a virus-like structure, MIT researchers have designed HIV-like particles that provoke a strong immune response from human immune cells grown in a lab dish. Such particles might eventually be used as an HIV vaccine.

READ MORE

Combination Therapy Improves Survival Rates for Women With Aggressive Endometrial Cancer in Phase 2 Trial

News

Yale Cancer Center scientists have found that combining the targeted drug trastuzumab with chemotherapy significantly improves survival rates for women with a rare, aggressive form of endometrial cancer.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE